Search Results - "McAndrew, Erin N."
-
1
The enigmatic oncogene and tumor suppressor‐like properties of RAD54B: Insights into genome instability and cancer
Published in Genes chromosomes & cancer (01-07-2017)“…One of the major challenges to the cell is to ensure genome stability, which can be compromised through endogenous errors or exogenous DNA damaging agents,…”
Get full text
Journal Article -
2
Long-term Survival Among Patients With De Novo Human Epidermal Growth Receptor 2-Positive Metastatic Breast Cancer in Manitoba
Published in American journal of clinical oncology (01-03-2024)“…Although metastatic breast cancer (MBC) is considered incurable, human epidermal growth receptor 2 (HER2)-directed therapy has improved outcomes significantly,…”
Get full text
Journal Article -
3
Treatment Patterns, Toxicity, and Outcomes of Older Adults With Advanced Pancreatic Cancer Receiving First-line Palliative Chemotherapy
Published in American journal of clinical oncology (01-02-2022)“…Advanced pancreatic cancer (APC) disproportionately impacts older adults. Randomized trials demonstrate improved overall survival (OS) with combination…”
Get full text
Journal Article -
4
The synthetic lethal killing of RAD54B-deficient colorectal cancer cells by PARP1 inhibition is enhanced with SOD1 inhibition
Published in Oncotarget (27-12-2016)“…Colorectal cancer (CRC) is a leading cause of cancer-related death throughout the world. Despite improved screening efforts, most CRCs are diagnosed at late…”
Get full text
Journal Article -
5
Capecitabine-mediated heart failure in colorectal cancer: a case series
Published in European heart journal : case reports (01-03-2021)“…Abstract Background Capecitabine is a pyrimidine antimetabolite that inhibits thymidylate synthase and is commonly used in the treatment of colorectal cancer…”
Get full text
Journal Article -
6
-
7
Abstract 2744: Synthetic lethal killing of RAD54B-deficient cancer cells by PARP1 silencing and inhibition
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Colorectal Cancer (CRC) is the second leading cause of cancer-related deaths in North America. Currently, many chemotherapeutics are non-specific and…”
Get full text
Journal Article